DeepMed Research

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2003-11-05

Last Posted Date: 2017-01-19

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT00072579

Locations: 🇺🇸
Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States
🇺🇸
CCOP - Columbus, Columbus, Ohio, United States
🇺🇸
CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

and more 12 locations

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2003-10-15

Last Posted Date: 2018-08-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT00015886

Locations: 🇺🇸
Cancer Centers of the Carolinas, Greenville, South Carolina, United States
🇺🇸
East Carolina University School of Medicine, Greenville, North Carolina, United States
🇺🇸
Palmetto Hematology/Oncology Associates, Spartanburg, South Carolina, United States

and more 3 locations

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer

Phase 3

Completed

Conditions: Weight Changes
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Megestrol Acetate
Drug: Oxandrolone 20 mg

First Posted Date: 2003-10-07

Last Posted Date: 2021-09-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 155

Registration Number: NCT00070148

Locations: 🇺🇸
CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
🇺🇸
Alamance Cancer Center at Alamance Regional Medical Center, Burlington, North Carolina, United States
🇺🇸
Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States

and more 17 locations

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

Phase 2

Completed

Conditions: Radiation Toxicity
Brain and Central Nervous System Tumors

First Posted Date: 2003-10-07

Last Posted Date: 2021-09-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 68

Registration Number: NCT00070161

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Regional Radiation Oncology Center at Rome, Rome, Georgia, United States
🇺🇸
CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

and more 1 locations

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

Phase 2

Completed

Conditions: Leukemia
Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes

First Posted Date: 2003-09-11

Last Posted Date: 2018-08-10

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT00068276

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression

Phase 3

Completed

Conditions: Depression
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Zoloft 50 mg
Dietary Supplement: St. John's Wort 600 mg

First Posted Date: 2003-08-07

Last Posted Date: 2021-09-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 2

Registration Number: NCT00066859

Locations: 🇺🇸
CCOP - Central Illinois, Decatur, Illinois, United States
🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Bay Area Tumor Institute, Oakland, California, United States

and more 3 locations

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Phase 3

Completed

Conditions: Anorexia
Cachexia
Lung Cancer

First Posted Date: 2003-08-06

Last Posted Date: 2021-09-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT00031785

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Phase 3

Completed

Conditions: Anorexia
Cachexia
Head and Neck Cancer
Quality of Life

First Posted Date: 2003-07-28

Last Posted Date: 2021-09-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 13

Registration Number: NCT00006799

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States

Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Dietary Supplement: placebo
Dietary Supplement: fruit and vegetable extracts

First Posted Date: 2003-07-09

Last Posted Date: 2021-09-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 134

Registration Number: NCT00064298

Locations: 🇺🇸
Redwood Regional Medical Group, Santa Rosa, California, United States
🇺🇸
MBCCOP - JHS Hospital of Cook County, Chicago, Illinois, United States
🇺🇸
CCOP - Central Illinois, Decatur, Illinois, United States

and more 25 locations

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Phase 3

Completed

Conditions: Lung Cancer

First Posted Date: 2003-07-01

Last Posted Date: 2021-09-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1

Registration Number: NCT00028938

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy